Kemper Corp Master Retirement Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-13,600
Closed -$924K 92
2017
Q1
$924K Sell
13,600
-1,400
-9% -$98.4K 0.6% 48
2016
Q4
$1.07M Hold
15,000
0.67% 52
2016
Q3
$1.19M Hold
15,000
0.74% 51
2016
Q2
$1.25M Hold
15,000
0.79% 48
2016
Q1
$1.38M Hold
15,000
0.71% 46
2015
Q4
$1.52M Hold
15,000
0.8% 43
2015
Q3
$1.47M Hold
15,000
0.72% 46
2015
Q2
$1.76M Hold
15,000
0.78% 39
2015
Q1
$1.47M Hold
15,000
0.65% 50
2014
Q4
$1.41M Hold
15,000
0.63% 48
2014
Q3
$1.6M Hold
15,000
0.63% 44
2014
Q2
$1.24M Buy
15,000
+10,000
+200% +$778K 0.45% 51
2014
Q1
$354K Buy
+5,000
New +$392K 0.13% 74

Other funds holding GILD

Kemper Corp Master Retirement Trust's GILD Position: Q2 2017 in Review

Kemper Corp Master Retirement Trust sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 13,600 shares — an estimated $924K sold.

Kemper Corp Master Retirement Trust first reported a position in GILD in Q1 2014 and held it in 13 quarters. The position peaked at $1.76M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Kemper Corp Master Retirement Trust reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Kemper Corp Master Retirement Trust sold 13,600 Gilead Sciences shares in Q2 2017, an estimated $924K.
  • Kemper Corp Master Retirement Trust first reported a position in Gilead Sciences in Q1 2014 and held it in 13 quarters.
  • Kemper Corp Master Retirement Trust's Gilead Sciences position peaked at $1.76M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Kemper Corp Master Retirement Trust's 13F filing for Q2 2017, filed 15 Aug 2017.